Status:

TERMINATED

A Feasibility Study to Evaluate the TURRIS Facet Fusion System in Lumbar Spinal Surgery

Lead Sponsor:

SpineWelding AG

Collaborating Sponsors:

ISS integrated Scientific Services AG

Conditions:

Spinal Disease

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This is a prospective, exploratory study to verify intra-operative handling and safety and to collect preliminary short-term safety and efficacy data of the Turris® Facet Fuser, a small bioresorbable ...

Detailed Description

The Turris® Facet Fuser is an investigational resorbable device intended to support spinal segment fusion in individuals suffering from degenerative lumbar spinal diseases. The device is directly inse...

Eligibility Criteria

Inclusion

  • one-level fusion at L4/L5 with dorsal instrumentation and, if required, with monolateral decompression and/or intervertebral disc removal and implantation of an intervertebral implant

Exclusion

  • Patient
  • had previous surgical stabilizations at the involved or adjacent levels
  • has lytic spondylolisthesis
  • has degenerative spondylolisthesis grade II or higher
  • has radiographic signs of significant instability and/or hypermobility of the segment (\>3mm translation, \>11° rotation difference from adjacent level)
  • has scoliosis \> 10° at the involved segment
  • has osteoporosis to a degree that spinal instrumentation would be contraindicated.
  • has presence of active malignancy.
  • has overt or active infection, either local or systemic
  • is less than 18 years old
  • is pregnant or plan a pregnancy during the study duration
  • has a BMI \> 35
  • has a progressive neuromuscular disease
  • has a condition which requires postoperative medications that may interfere with bone metabolism
  • has a history of autoimmune disease
  • has a history of endocrine or metabolic disorders known to affect osteogenesis
  • is mentally ill or incompetent
  • is an alcohol and/or drug abuser
  • is not available for follow up visits

Key Trial Info

Start Date :

February 1 2015

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 18 2016

Estimated Enrollment :

3 Patients enrolled

Trial Details

Trial ID

NCT02294669

Start Date

February 1 2015

End Date

June 18 2016

Last Update

April 4 2022

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Neuro- und Wirbelsäulenzentrum

Cham, CH, Switzerland, 6330

2

Rückenzentrum Oberaargau AG

Langenthal, Switzerland, 4900